title: Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity.
abstract: Activation of immune cells, including macrophages and CD8(+) T cells, contributes significantly to the advancement of obesity and its associated medical complications, such as atherosclerosis, insulin resistance, and type 2 diabetes. However, how the activation of these immune cells is regulated in vivo remains largely unexplored. Here we show that a group of immature myeloid cells with cell surface markers of Gr-1(+) CD11b(+) are highly enriched in peripheral tissues (i.e. liver and adipose tissues) during obesity. Down-regulation of these cells in obese animals significantly increases inflammation and impairs insulin sensitivity and glucose tolerance, whereas elevation of these cells via adoptive transfer has the opposite effects. Mechanistically, we show that under obese conditions, the Gr-1(+) cells suppress proliferation and induce apoptosis of CD8(+) T cells and are capable of skewing differentiation of macrophages into insulin-sensitizing, alternatively activated M2 macrophages. Taken together, our study demonstrates that immature myeloid cells provide a checks-and-balances platform to counter proinflammatory immune cells in the liver and adipose tissue during obesity to prevent overt immune responses.
authors: Division of Nutritional Sciences, Cornell University, Ithaca, New York 14853, USA. sx43@cornell.edu
authors: Sheng
authors: S
authors: Xia
authors: Haibo
authors: H
authors: Sha
authors: Liu
authors: L
authors: Yang
authors: Yewei
authors: Y
authors: Ji
authors: Suzanne
authors: S
authors: Ostrand-Rosenberg
authors: Ling
authors: L
authors: Qi
references: Blood. 2008 Nov 15;112(10):4080-9
references: 18753637
references: Curr Pharm Des. 2008;14(12):1225-30
references: 18473870
references: Nat Immunol. 2010 Jan;11(1):7-13
references: 20016504
references: J Neurosci. 2009 Jan 21;29(3):753-64
references: 19158301
references: Cancer Res. 2009 Jul 1;69(13):5514-21
references: 19549903
references: J Immunol. 2008 Oct 15;181(8):5791-802
references: 18832739
references: Science. 2010 Feb 5;327(5966):656-61
references: 20133564
references: J Leukoc Biol. 1984 Oct;36(4):505-20
references: 6384406
references: Cell Metab. 2009 Jun;9(6):556-64
references: 19490910
references: Cancer Res. 2007 May 1;67(9):4346-52
references: 17483348
references: Cancer Res. 1992 Nov 15;52(22):6335-40
references: 1423279
references: Nat Med. 2009 Aug;15(8):930-9
references: 19633656
references: Cell. 2008 Sep 19;134(6):933-44
references: 18805087
references: J Immunol. 2001 Nov 15;167(10):5583-93
references: 11698429
references: J Clin Invest. 2007 May;117(5):1155-66
references: 17476345
references: Cell Metab. 2009 Mar;9(3):277-86
references: 19254572
references: Cell Metab. 2007 Aug;6(2):137-43
references: 17681149
references: J Lipid Res. 2007 Feb;48(2):465-71
references: 17093294
references: J Clin Invest. 2007 Jan;117(1):175-84
references: 17200717
references: J Leukoc Biol. 2008 Jan;83(1):64-70
references: 17884993
references: Nat Rev Immunol. 2009 Mar;9(3):162-74
references: 19197294
references: Nat Med. 2009 Aug;15(8):914-20
references: 19633658
references: Immunity. 2003 Jul;19(1):71-82
references: 12871640
references: J Clin Invest. 2003 Dec;112(12):1821-30
references: 14679177
references: Nat Rev Immunol. 2003 Jan;3(1):23-35
references: 12511873
references: Annu Rev Physiol. 2010;72:219-46
references: 20148674
references: Blood. 2008 Oct 15;112(8):3175-85
references: 18669892
references: J Clin Invest. 2006 Jul;116(7):1793-801
references: 16823477
references: J Clin Invest. 2007 Jun;117(6):1658-69
references: 17525798
references: J Immunol. 2009 Apr 15;182(8):4499-506
references: 19342621
references: J Exp Med. 2003 Dec 1;198(11):1741-52
references: 14657224
references: Clin Cancer Res. 1995 Jan;1(1):95-103
references: 9815891
references: Nature. 2007 Jun 28;447(7148):1116-20
references: 17515919
references: Nat Med. 2009 Aug;15(8):921-9
references: 19633657
references: Curr Opin Genet Dev. 2008 Feb;18(1):11-8
references: 18308558
references: Nature. 2002 Nov 21;420(6913):333-6
references: 12447443
references: J Immunol. 2001 Jan 1;166(1):678-89
references: 11123353
references: Blood. 2000 Dec 1;96(12):3838-46
references: 11090068
references: J Immunol. 2007 Jul 15;179(2):977-83
references: 17617589
references: Cancer Res. 2007 Jan 1;67(1):425; author reply 426
references: 17210725
references: J Clin Invest. 2003 Dec;112(12):1796-808
references: 14679176
references: Cell Metab. 2008 Jun;7(6):496-507
references: 18522831
references: J Immunol. 2009 Jan 1;182(1):240-9
references: 19109155
references: Clin Exp Metastasis. 1999;17(10):881-8
references: 11089887